ArticleMolecular medicine (Cambridge, Mass.)2016

Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.

Noriko Satake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.